Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine augmentation in treatment-resistant obsessive compulsive disorder
IRCT2015062422901N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of buprenorphine in obsessive compulsive disorder (OCD), sponsored by Hamadan University of Medical Sciences. Started Sep 2015; status: completed.
02
Drugs
buprenorphine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT2015062422901N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015062422901N1.